The latest pancreatic cancer news
‘Promising’ antibody therapy extends survival in mice with pancreatic cancer
Scientists have found a way to target and knock out a single protein that they…
The latest pancreatic cancer news
Scientists have found a way to target and knock out a single protein that they…
In a proof-of-concept study, an international scientific team led by Johns Hopkins Kimmel Cancer Center…
Mariano Barbacid, Centro Nacional de Investigaciones Oncológicas CNIO Pancreatic ductal adenocarcinoma (PDAC), the most common…
A widely recognised biomarker for pancreatic disease, CA19-9, thought to be benign for decades, may…
The randomised, phase III POLO trial found that maintenance therapy with the PARP inhibitor olaparib…
Nathan Bahary, University of Pittsburgh With Alex Trebek’s recent announcement that his pancreatic cancer is…
Advanced pancreatic cancer is often symptomless, leading to late diagnosis only after metastases have spread…
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer…
Switching pancreatic cancer patients to the PARP inhibitor rucaparib as maintenance therapy instead of continuing…
Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk…